Patents by Inventor Jason E Dougherty
Jason E Dougherty has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 9919151Abstract: Devices, systems and methods for controlling the application of current and/or voltage to deliver drug from patient contacts of an electrotransport drug delivery device by indirectly controlling and/or monitoring the applied current without directly measuring from the cathode of the patient terminal. In particular, described herein are electrotransport drug delivery systems including constant current delivery systems having a feedback current and/or voltage control module that is isolated from the patient contacts (e.g., anodes and cathodes). The feedback module may be isolated by a transistor from the patient contacts; feedback current and/or voltage control measurements may be performed at the transistor rather than at the patient contact (e.g., cathode).Type: GrantFiled: March 5, 2013Date of Patent: March 20, 2018Assignees: Incline Therapeutics, Inc., Alza CorporationInventors: Bradley E. White, Paul Hayter, John Lemke, Scot Satre, Corinna X. Chen, Brian W. Read, Jason E. Dougherty
-
Publication number: 20170239468Abstract: A switch-operated therapeutic agent delivery device. Embodiments of the operated therapeutic agent delivery device my include a switch that can be operated by a user, a device controller connected to the switch through a switch input where the device can actuate the device when certain predetermined conditions are met, following performance of both a digital switch validation test and an analog switch validation test. The switch operated therapeutic agent delivery device may have two parts, which are assembled by a user prior to use. These devices may be configured to determine if a current is present between the anode and cathode when drug is not intended to be delivered by the device. These devices may indirectly control and/or monitor the applied current without directly measuring from the cathode of the patient terminal.Type: ApplicationFiled: May 8, 2017Publication date: August 24, 2017Inventors: John LEMKE, Scot SATRE, Corinna X. CHEN, Brian W. READ, Zita S. NETZEL, David SEWARD, Bradley E. WHITE, Paul HAYTER, Jason E. DOUGHERTY
-
Patent number: 9731121Abstract: A switch-operated therapeutic agent delivery device is described. Embodiments of the operated therapeutic agent delivery device include a switch that can be operated by a user, a device controller connected to the switch through a switch input where the device can actuate the device when certain predetermined conditions are met, following performance of both a digital switch validation test and an analog switch validation test.Type: GrantFiled: June 4, 2014Date of Patent: August 15, 2017Assignee: Incline Therapeutics, Inc.Inventors: John Lemke, Scot Satre, Corinna X. Chen, Brian W. Read, Jason E. Dougherty, Nitin B. Joshi
-
Patent number: 9645179Abstract: Electrotransport drug delivery devices, system and methods of using configured to determine if a current is present between the anode and cathode when drug is not intended to be delivered by the device. These devices/systems may include an off-current module to determine that any current (e.g., which may be inferred by measuring potential difference between the anode and cathode of the device) flowing between the anode and cathode is below a threshold value when the device is not supposed to be delivering drug, thereby preventing unintended delivery of drug and/or alerting a user that unintended delivery of drug may occur.Type: GrantFiled: July 31, 2015Date of Patent: May 9, 2017Assignees: Incline Therapeutics, Inc., Alza CorporationInventors: Bradley E. White, John Lemke, Paul Hayter, Corinna X. Chen, Brian W. Read, Jason E. Dougherty
-
Publication number: 20150338445Abstract: Electrotransport drug delivery devices, system and methods of using configured to determine if a current is present between the anode and cathode when drug is not intended to be delivered by the device. These devices/systems may include an off-current module to determine that any current (e.g., which may be inferred by measuring potential difference between the anode and cathode of the device) flowing between the anode and cathode is below a threshold value when the device is not supposed to be delivering drug, thereby preventing unintended delivery of drug and/or alerting a user that unintended delivery of drug may occur.Type: ApplicationFiled: July 31, 2015Publication date: November 26, 2015Inventors: Bradley E. WHITE, John LEMKE, Paul HAYTER, Corinna X. CHEN, Brian W. READ, Jason E. DOUGHERTY
-
Patent number: 9095706Abstract: Electrotransport drug delivery devices, system and methods of using configured to determine if a current is present between the anode and cathode when drug is not intended to be delivered by the device. These devices/systems may include an off-current module to determine that any current (e.g., which may be inferred by measuring potential difference between the anode and cathode of the device) flowing between the anode and cathode is below a threshold value when the device is not supposed to be delivering drug, thereby preventing unintended delivery of drug and/or alerting a user that unintended delivery of drug may occur.Type: GrantFiled: April 19, 2013Date of Patent: August 4, 2015Assignees: Incline Therapeutics, Inc., Alza CorporationInventors: Bradley E. White, John Lemke, Paul Hayter, Corinna X. Chen, Brian W. Read, Jason E. Dougherty
-
Publication number: 20150196754Abstract: Devices, systems and methods for controlling the application of current and/or voltage to deliver drug from patient contacts of an electrotransport drug delivery device by indirectly controlling and/or monitoring the applied current without directly measuring from the cathode of the patient terminal. In particular, described herein are electrotransport drug delivery systems including constant current delivery systems having a feedback current and/or voltage control module that is isolated from the patient contacts (e.g., anodes and cathodes). The feedback module may be isolated by a transistor from the patient contacts; feedback current and/or voltage control measurements may be performed at the transistor rather than at the patient contact (e.g., cathode).Type: ApplicationFiled: March 5, 2013Publication date: July 16, 2015Applicants: ALZA CORPORATION, INCLINE THERAPEUTICS, INC.Inventors: Bradley E. White, Paul Hayter, John Lemke, Scot Satre, Corinna X. Chen, Brian W. Read, Jason E. Dougherty
-
Publication number: 20140288526Abstract: A switch-operated therapeutic agent delivery device is described. Embodiments of the operated therapeutic agent delivery device include a switch that can be operated by a user, a device controller connected to the switch through a switch input where the device can actuate the device when certain predetermined conditions are met, following performance of both a digital switch validation test and an analog switch validation test.Type: ApplicationFiled: June 4, 2014Publication date: September 25, 2014Inventors: John LEMKE, Scot SATRE, Corinna X. CHEN, Brian W. READ, Jason E. Dougherty, Nitin B. Joshi
-
Publication number: 20130310729Abstract: Electrotransport drug delivery devices, system and methods of using configured to determine if a current is present between the anode and cathode when drug is not intended to be delivered by the device. These devices/systems may include an off-current module to determine that any current (e.g., which may be inferred by measuring potential difference between the anode and cathode of the device) flowing between the anode and cathode is below a threshold value when the device is not supposed to be delivering drug, thereby preventing unintended delivery of drug and/or alerting a user that unintended delivery of drug may occur.Type: ApplicationFiled: April 19, 2013Publication date: November 21, 2013Inventors: Bradley E. WHITE, John LEMKE, Paul HAYTER, Corinna X. CHEN, Brian W. READ, Jason E. DOUGHERTY
-
Patent number: 8428709Abstract: Devices, systems and methods for controlling the application of current and/or voltage to deliver drug from patient contacts of an electrotransport drug delivery device by indirectly controlling and/or monitoring the applied current without directly measuring from the cathode of the patient terminal. In particular, described herein are electrotransport drug delivery systems including constant current delivery systems having a feedback current and/or voltage control module that is isolated from the patient contacts (e.g., anodes and cathodes). The feedback module may be isolated by a transistor from the patient contacts; feedback current and/or voltage control measurements may be performed at the transistor rather than at the patient contact (e.g., cathode).Type: GrantFiled: June 11, 2012Date of Patent: April 23, 2013Assignees: Incline Therapeutics, Inc., Alza CorporationInventors: Bradley E. White, Paul Hayter, John Lemke, Scot Satre, Corinna X. Chen, Brian W. Read, Jason E. Dougherty
-
Patent number: 8428708Abstract: Electrotransport drug delivery devices, system and methods of using configured to determine if a current is present between the anode and cathode when drug is not intended to be delivered by the device. These devices/systems may include an off-current module to determine that any current (e.g., which may be inferred by measuring potential difference between the anode and cathode of the device) flowing between the anode and cathode is below a threshold value when the device is not supposed to be delivering drug, thereby preventing unintended delivery of drug and/or alerting a user that unintended delivery of drug may occur.Type: GrantFiled: May 21, 2012Date of Patent: April 23, 2013Assignees: Incline Therapeutics, Inc., Alza CorporationInventors: Bradley E. White, John Lemke, Paul Hayter, Corinna X. Chen, Brian W. Read, Jason E. Dougherty
-
Patent number: 7302318Abstract: A method (200) is disclosed for designing an RNP approach for an aircraft at a particular runway (90). The method includes selecting a runway (201), gathering obstacle data for the obstacle evaluation area (202), selecting a VEB method and terms (204), laying out a preliminary approach, inducing a missed approach segment (206), calculating a preliminary obstacle clearance surface (208), calculating a momentary descent segment using a physical model of the aircraft (210), adjusting the obstacle clearance surface so that no obstacles intersect the surface (212), and optionally optimizing the approach by departing from the operator's standard procedures (214). Preferably, the obstacle clearance surface is adjusted so that it just touches an obstacle, without any object intersecting the surface, thereby providing an optimal decision altitude.Type: GrantFiled: March 10, 2006Date of Patent: November 27, 2007Assignee: Naverus, Inc.Inventors: Daniel A Gerrity, Jason E Dougherty, John H Andersen, Stephen D Fulton